BPA - Laboratory Supplies/Reagents - Crownpoint Healthcare Facility

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAVAJO AREA INDIAN HEALTH SVC

Contract Value

Not provided

Codes & Classification
Solicitation Number

75H71026Q00179

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

BICiv

Place of Performance

Crownpoint, New Mexico, UNITED STATES

SourceSAM
Documents4
The Navajo Area Indian Health Service (IHS), operating under the Department of Health and Human Services, has issued a Combined Synopsis/Solicitation (Solicitation No. 75H71026Q00179) for the establishment of a Blanket Purchase Agreement (BPA) to supply laboratory supplies, reagents, diagnostic test kits, collection supplies, quality control materials, and related laboratory consumables to the Crownpoint Healthcare Facility Laboratory in Crownpoint, New Mexico. This procurement is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with a size standard of 1,250 employees, and is further identified by Product Service Code 6550. The primary objective of this solicitation is to ensure the Crownpoint Healthcare Facility Laboratory has reliable, timely access to a comprehensive range of laboratory consumables and reagents necessary for diagnostic and clinical operations. The scope of the agreement encompasses the provision of both brand-name and equivalent products, as specified in the Statement of Work (SOW) and the Laboratory Supply Evaluation Schedule (Attachment 1). Manufacturer names and part numbers are included for reference and evaluation purposes; however, equivalent items may be proposed, subject to government review and acceptance for technical suitability. This opportunity is a 100% Indian Small Business Economic Enterprise (ISBEE) set-aside, conducted under the Buy Indian Act. Only eligible Indian-owned small businesses are invited to participate, supporting the economic development of Native American enterprises. The solicitation incorporates all applicable federal acquisition provisions and clauses, which are available for review at www.acquisition.gov and www.acquisition.gov/hhsar. The BPA will cover a base period from October 1, 2026, through September 30, 2027, with an option period extending from October 1, 2027, through September 30, 2028. All deliveries are to be made FOB Destination to the Crownpoint Healthcare Facility, located in Crownpoint, New Mexico (ZIP code 87313). Delivery timelines will be determined based on the contractor’s proposal and must be adhered to unless the contractor promptly notifies the government of any anticipated delays or backorders. Orders will be placed on an as-needed basis, reflecting the actual requirements of the laboratory; the supply list provided is representative and not exhaustive. Interested offerors are required to review the full Combined Synopsis/Solicitation and all attachments for detailed requirements, submission instructions, evaluation criteria, and terms and conditions. The government expects contractors to provide high-quality, technically acceptable products, with flexibility to accommodate evolving laboratory needs over the contract period. For further information or clarification, prospective offerors may contact the primary contracting officer, Marshall Arviso, at [email protected] or 505-786-6319, or the secondary contact, Janice Martinez, at [email protected] or 505-786-6216. This procurement represents a significant opportunity for qualified Indian-owned small businesses specializing in laboratory supplies and in-vitro diagnostic substances to support the healthcare needs of the Navajo Nation through the Crownpoint Healthcare Facility.